How Did the 2003 Prescription Drug Re-Importation Bill Pass the House?
dc.contributor.author | Adams, Mike | |
dc.contributor.author | Gokcekus, Omer | |
dc.contributor.author | Grabowski, Henry G | |
dc.contributor.author | Tower, Edward | |
dc.date.accessioned | 2010-03-09T15:41:21Z | |
dc.date.available | 2010-03-09T15:41:21Z | |
dc.date.issued | 2006 | |
dc.description.abstract | the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies - employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: party affiliation was the most important factor in passing the bill. | |
dc.format.extent | 144967 bytes | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | ||
dc.language.iso | en_US | |
dc.publisher | SSRN eLibrary | |
dc.subject | instrumental variables | |
dc.subject | logit model | |
dc.subject | prescription drugs | |
dc.title | How Did the 2003 Prescription Drug Re-Importation Bill Pass the House? | |
dc.type | Journal article |
Files
Original bundle
- Name:
- Grabowski_how_did_the_prescription_drug.pdf
- Size:
- 141.57 KB
- Format:
- Adobe Portable Document Format